Search

Your search keyword '"Vella, S."' showing total 45 results

Search Constraints

Start Over You searched for: Author "Vella, S." Remove constraint Author: "Vella, S." Topic medicine Remove constraint Topic: medicine
45 results on '"Vella, S."'

Search Results

1. Optimization of hepatitis C virus screening strategies by birth cohort in Italy

2. CD4/CD8 ratio in pregnant women with HIV and its association with pregnancy outcome: data from a national study in Italy

3. Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data

4. Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response:a sub-study of the NEAT001/ANRS143 randomized trial

5. Atazanavir and darunavir in pregnant women with HIV: evaluation of laboratory and clinical outcomes from an observational national study

6. Weight Gain during Pregnancy in Women with HIV Receiving Different Antiretroviral Regimens

7. Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals?

8. Amniocentesis and chorionic villus sampling in HIV-infected pregnant women: a multicentre case series

9. Evolving treatment implementation among HIV- infected pregnant women and their partners: Results from a national surveillance study in Italy, 2001-2015

10. Modeling cost-effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real-life cohort

11. Pregnant with HIV before age 25: Data from a large national study in Italy, 2001-2016

12. Neurocognition and quality of life after reinitiating antiretroviral therapy in children randomized to planned treatment interruption

13. HCV-related mixed cryoglobulinemia: Data from PITER, a nationwide Italian HCV cohort study

14. Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy

15. An update to the HIV-TRePS system: The development and evaluation of new global and local computational models to predict HIV treatment outcomes, with or without a genotype

16. Tuberculosis among HIV-positive patients across Europe: changes over time and risk factors

17. Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study

18. Hyaluronic acid levels predict risk of hepatic encephalopathy and liver-related death in HIV/viral hepatitis coinfected patients

19. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study

20. Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial

21. Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study

22. Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation

23. A Randomized Trial Comparing the Introduction of Ritonavir or Indinavir in 1251 Nucleoside-Experienced Patients with Advanced HIV Infection

24. Body Mass Index and Weight Gain in Pregnant Women With HIV: A National Study in Italy

25. The immunological and virological consequences of planned treatment interruptions in children with HIV infection

26. Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011

27. Attention-deficit/hyperactivity disorder drugs and growth: an Italian prospective observational study

28. Replication capacity in relation to immunologic and virologic outcomes in HIV-1-infected treatment-naive subjects

29. Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children

30. Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: The Istituto Superiore di Sanità-Pulsed Antiretroviral Therapy (ISS-PART) study

31. Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network

32. Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV

33. Co-administration of fendiline hydrochloride enhances chemotherapeutic efficacy of cisplatin in neuroblastoma treatment

34. Comparison of Immunosuppressive and Angiogenic Properties of Human Amnion-Derived Mesenchymal Stem Cells between 2D and 3D Culture Systems

35. Case of primary hepatic leiomyosarcoma successfully treated with laparoscopic right hepatectomy

36. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

37. GENDER DIFFERENCES IN HCV CHRONIC LIVER DISEASE: A REAL LIFE EVALUATION IN PITER (PIATTAFORMA ITALIANA PER LO STUDIO DELLA TERAPIA DELLE EPATITI VIRALI) COHORT STUDY

38. Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study

39. A 'systems medicine' approach to the study of non-alcoholic fatty liver disease

40. Antisense versus proopiomelanocortin mRNA reduces vascular risk in a murine model of type-2 diabetes following stress exposure in early post-natal life

41. Virus Variability and Its Impact on HIV and Hepatitis Therapy

42. Sexual dimorphic evolution of metabolic programming in non-genetic non-alimentary mild metabolic syndrome model in mice depends on feed-back mechanisms integrity for pro-opiomelanocortin-derived endogenous substances

43. The Effects of AZT and DDI on Pre- and Postimplantation Mammalian Embryos: An In Vivo and In Vitro Study

44. Post-natal stress-induced endocrine and metabolic alterations in mice at adulthood involve different pro-opiomelanocortin-derived peptides

45. Predictors of trend in CD4-positive T-cell count and mortality among HIV-1 infected individuals with virological failure to all three antiretroviral-drug classes

Catalog

Books, media, physical & digital resources